| Impact of CYP2C19 genetic polymorphisms on voriconazole dosing and exposure in adult patients with invasive fungal infections F Lamoureux, T Duflot, JB Woillard, D Metsu, T Pereira, P Compagnon, ... International journal of antimicrobial agents 47 (2), 124-131, 2016 | 96 | 2016 |
| Pharmacogenetics of direct oral anticoagulants: a systematic review J Raymond, L Imbert, T Cousin, T Duflot, R Varin, J Wils, F Lamoureux Journal of Personalized Medicine 11 (1), 37, 2021 | 91 | 2021 |
| Design and discovery of soluble epoxide hydrolase inhibitors for the treatment of cardiovascular diseases T Duflot, C Roche, F Lamoureux, D Guerrot, J Bellien Expert opinion on drug discovery 9 (3), 229-243, 2014 | 43 | 2014 |
| Impact of soluble epoxide hydrolase inhibition on early kidney damage in hyperglycemic overweight mice C Roche, D Guerrot, N Harouki, T Duflot, M Besnier, I Rémy-Jouet, ... Prostaglandins & other lipid mediators 120, 148-154, 2015 | 35 | 2015 |
| Discovery of the first in vivo active inhibitors of the soluble epoxide hydrolase phosphatase domain JS Kramer, S Woltersdorf, T Duflot, K Hiesinger, FF Lillich, F Knöll, ... Journal of medicinal chemistry 62 (18), 8443-8460, 2019 | 33 | 2019 |
| Development of improved double-nanobody sandwich ELISAs for human soluble epoxide hydrolase detection in peripheral blood mononuclear cells of diabetic patients and the … D Li, C Morisseau, CB McReynolds, T Duflot, J Bellien, RM Nagra, ... Analytical chemistry 92 (10), 7334-7342, 2020 | 32 | 2020 |
| The right blood collection tube for therapeutic drug monitoring and toxicology screening procedures: Standard tubes, gel or mechanical separator? A Schrapp, C Mory, T Duflot, T Pereira, L Imbert, F Lamoureux Clinica Chimica Acta 488, 196-201, 2019 | 32 | 2019 |
| Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of Pharmacogenetics (RNPGx) F Lamoureux, T Duflot Therapies 72 (2), 257-267, 2017 | 25 | 2017 |
| Altered bioavailability of epoxyeicosatrienoic acids is associated with conduit artery endothelial dysfunction in type 2 diabetic patients T Duflot, L Moreau-Grangé, C Roche, M Iacob, J Wils, I Rémy-Jouet, ... Cardiovascular diabetology 18, 1-12, 2019 | 24 | 2019 |
| Physiological role of endothelin-1 in flow-mediated vasodilatation in humans and impact of cardiovascular risk factors J Bellien, M Iacob, C Monteil, I Rémy-Jouet, C Roche, T Duflot, ... Journal of Hypertension 35 (6), 1204-1212, 2017 | 24 | 2017 |
| A sensitive LC-MS/MS method for the quantification of regioisomers of epoxyeicosatrienoic and dihydroxyeicosatrienoic acids in human plasma during endothelial stimulation T Duflot, T Pereira, C Roche, M Iacob, P Cardinael, NEG Hamza, ... Analytical and bioanalytical chemistry 409, 1845-1855, 2017 | 23 | 2017 |
| Investigation of coagulation biomarkers to assess clinical deterioration in SARS-CoV-2 infection P Billoir, K Alexandre, T Duflot, M Roger, S Miranda, O Goria, LM Joly, ... Frontiers in Medicine 8, 670694, 2021 | 22 | 2021 |
| Impact of CYP3A4 Genotype on Voriconazole Exposure. T Duflot, A Schrapp, J Bellien, F Lamoureux Clinical Pharmacology and Therapeutics 103 (2), 185-186, 2017 | 20 | 2017 |
| Alteration in the availability of epoxyeicosatrienoic acids contributes with NO to the development of endothelial dysfunction in conduit arteries during aging J Wils, Z Djerada, F Roca, T Duflot, M Iacob, I Remy-Jouet, R Joannides, ... Atherosclerosis 275, 239-245, 2018 | 17 | 2018 |
| Ten-year evaluation of a large retrospective cohort treated by sacral nerve modulation for fecal incontinence: results of a French multicenter study C Desprez, H Damon, G Meurette, D Mege, JL Faucheron, C Brochard, ... Annals of Surgery 275 (4), 735-742, 2022 | 16 | 2022 |
| Thrombin generation profile in non-thrombotic factor V Leiden carriers P Billoir, T Duflot, M Fresel, MH Chrétien, V Barbay, V Le Cam Duchez Journal of thrombosis and thrombolysis 47, 473-477, 2019 | 16 | 2019 |
| Fostering global data sharing: highlighting the recommendations of the Research Data Alliance COVID-19 working group CC Austin, A Bernier, L Bezuidenhout, J Bicarregui, T Biro, ... Wellcome open research 5, 2020 | 15 | 2020 |
| French Network of Pharmacogenetics (RNPGX). Pharmacogenetics in cardiovascular diseases: State of the art and implementation-recommendations of the French National Network of … F Lamoureux, T Duflot Therapie 72 (2), 257-267, 2017 | 12 | 2017 |
| CRISPR/Cas9-mediated inactivation of the phosphatase activity of soluble epoxide hydrolase prevents obesity and cardiac ischemic injury M Leuillier, T Duflot, S Ménoret, H Messaoudi, Z Djerada, D Groussard, ... Journal of advanced research 43, 163-174, 2023 | 10 | 2023 |
| Exploring the microvascular impact of red blood cell transfusion in intensive care unit patients G Hariri, S Bourcier, Z Marjanovic, J Joffre, J Lemarié, JR Lavillegrand, ... Critical Care 23, 1-10, 2019 | 10 | 2019 |
